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Abstract: Wholegrain (WG) consumption has been associated with reduced risk factors for cardiorenal
metabolic diseases (CRMD). In Latin-America. WG intake is low and scarce studies on this subject
have been found. We aimed to evaluate the association between WG consumption and risk factors
for CRMD in the 2016–2017 Chilean-National Health Survey. This cross-sectional study included
3110 participants representative of a total population of 11,810,647 subjects > 18 y, not taking
insulin and with complete data on CRMD risk factors. Outcomes were metabolic syndrome and
its components, albuminuria, and impaired glomerular filtration rate (GFR). WG consumption
was categorized as regular (≥every two days), sporadic (≥once a month), and non-consumers.
Associations were analyzed by multivariable logistic regressions adjusted for confounders taking
into account the complex sample design of the survey. Regular WG consumers showed a lower risk
of high blood pressure (OR: 0.61, 95%CI: 0.41–0.91) compared to non-consumers in fully-adjusted
models. Although inverse associations were noticed with other metabolic syndrome components
and impaired GFR, none was statistically significant. The association between WG and BP remained
robust in the sensitivity analysis. In conclusion regular WG consumption was associated with a 39%
lower risk of high blood pressure in Chilean adults.
Keywords: wholegrain; cardiovascular disease; metabolic syndrome; chronic kidney disease;
Latin America
1. Introduction
Non-communicable diseases are one of the major causes of overall mortality, from which
cardiovascular diseases are the leading cause of death worldwide [1]. Cardiovascular, renal, and metabolic
diseases (CRMD) share several risk factors and simulation studies have showed that policies and
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interventions promoting a healthy lifestyle, including a healthy diet, may significantly reduce the
incidence rates of CRMD in the years to come [2].
Wholegrain (WG) consumption has been associated with a lower incidence of CRMD in a recent
meta-analysis of cohort studies and clinical trials [3]. In randomized clinical trials, WG interventions
reduced several risk factors for CRMD, such as blood pressure (BP) and total cholesterol levels [3].
However, to our knowledge, no studies have evaluated these associations in a Latin-American population.
The Latin American Study of Nutrition and Health (ELANS) showed that WG consumption is
scarce and represents approximately 1% of total energy intake [4]. Moreover, in the whole ELANS
cohort only 36.3% of the participants consumed WG foods; while in the Chilean sub-cohort, this was
even lower, at 27.9% [5]. Among the participants who consumed WG in the ELANS-Chile, dietary
WG intake was relatively low with an estimated median of 40 g/day (p25–p75: 20–80 g/day) [5].
Similarly, the previous Chile National Health Survey (2009–2010) showed that only 30.3% of the
Chilean population regularly consumes WG foods, while 61.3% never consumed them [6].
The National Survey of Food Consumption in Chile (ENCA) showed that only 5% of the Chilean
population followed a healthy diet as defined by the Food Based Dietary Guideline for the Chilean
population [7,8]. Briefly, this guideline defines a healthy diet, encouraging the consumption of fruits
and vegetables five times/day, of dairy products low in fat and sugar three times/day and of legumes
and fish at least two times/week, as well as lowering added-salt consumption and avoiding sugar, candy,
sweetened drinks and juices, and fried foods [7]. Previous results from the 2016–2017 Chilean National
Health Survey showed that the risk for metabolic syndrome was inversely associated with higher
consumption of fruits and vegetables or with moderate-vigorous physical activity among participants
with normal weight or obesity, respectively [9]. In their analysis, the authors only analyzed the
consumption of fruits/vegetables and of fish/seafood, but, similarly to the national dietary guidelines,
they omitted WG consumption. Reynolds et al. [3] identified a linear dose-response relationship
showing that a 15 g/day increase of WG intake was associated with a reduction of 7% and 12% of
relative risk for incident coronary heart disease and type 2 diabetes, respectively. Therefore, the impact
of WG consumption on CRMD risk factors has yet to be determined in a Latin-American population
characterized by low levels of intake. The aim of the study was to evaluate the association between
WG consumption and risk factors for CRMD in the 2016–2017 Chilean National Health Survey.
2. Materials and Methods
2.1. Study Sample
The 2016–2017 Chilean National Health Survey was a survey with a stratified multistage
sample of non-institutionalized participants over 14 years old from urban and rural regions in
Chile. Detailed information about the survey has been described elsewhere [10]. In the present
study, from the 6233 participants recruited, 3110 subjects with age ≥ 18 years, with complete data on
CRMD risk factors and covariates, and not taking insulin were included in this analysis (Figure 1).
All participants signed the written consent form. The Ethics Committee from the Pontificia Universidad
Católica (PUC) de Chile approved the study protocol (Number: 16–019).
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Figure 1. Flowchart of participants in the 2016–2017 Chilean National Health Survey. 
2.2. Dietary Exposure 
Dietary assessment was carried out by trained interviewers collecting information on the 
frequency of consumption of fish and seafood, dairy products, WG products, fruits, vegetables, 
legumes, sugar-sweetened beverages and culinary fat. These questions were designed by experts 
based on the Food Based Dietary Guideline (FBDG) for the Chilean population as described in the 
2009–2010 Chilean National Health Survey [6,7]. 
WG consumption was classified in three categories according to the question: how often do you 
consume any WG cereal, such as WG bread, WG cereal or any other food that contains WG flour? 
Regular WG consumers were participants who answered, “more than once a day”, “once a day” or 
“every two days”. Sporadic WG consumers were those who answered, “at least once a week” or 
“once a month”. Non-consumers were those that reported that they “never consume WG foods”. 
The consumption of fruits, vegetables and legumes were selected as dietary covariates because 
they are also important sources of dietary fiber. Consumption of fruits and vegetables was estimated 
through the questions: “Typically, how many days a week do you eat fruits?” and “Typically, how 
many days a week do you eat vegetables or vegetable salad? (do not include legumes or potatoes)”, 
respectively. The answers in days per week were used as continuous variables. Consumption of 
legumes was assessed through the question: “How often do you consume any type of legumes, such 
as beans, lentils, green peas or chickpeas?” They were grouped into three categories: (i) “two or more 
times per week”, (ii) between “at least once a week” and “between one and three times a month”, 
and (iii) “less than once a month or never”. 
2.3. Assessment of Risk Factors for Cardiorenal Metabolic Disease 
Waist circumference was measured at the midpoint between the costal margin and the iliac crest. 
Medication use for diabetes and BP was self-reported. BP was measured three times and the mean 
was used in the study. Fasting blood samples (at least 8 h fast) were drawn for the evaluation of 
glucose, hemoglobin A1c (HbA1c), creatinine and plasma lipids by standardized methods in a 
centralized laboratory as described previously. A morning urine sample was collected at the moment 
of the visit (7–10 am) to measure the urinary albumin-creatinine ratio (uACR) [10]. Urinary albumin 
values below the lowest reportable value (<0.003 g/L) were replaced by 0.003 g/L and included in the 
analysis. Very low-density lipoprotein-cholesterol (VLDL-C) and non-high-density lipoprotein-
cholesterol (non-HDL-C) and the triglycerides/HDL-C ratio were calculated. The Chronic Kidney 
Disease-Epidemiology Collaboration (CKD-EPI) formula was used to estimate the glomerular 
filtration rate (GFR) [11]. 
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2.2. Dietary Exposure
Dietary assessment was carried out by trained interviewers collecting information on the frequency
of consumption of fish and seafood, dairy products, WG products, fruits, vegetables, legumes,
sugar-sweetened beverages and culinary fat. These questions were designed by experts based on
the Food Based Dietary Guideline (FBDG) for the Chilean population as described in the 2009–2010
Chilean National Health Survey [6,7].
WG consumption was classified in three categories according to the question: how often do you
consume any WG cereal, such as WG bread, WG cereal or any other food that contains WG flour?
Regular WG consumers were participants who answered, “more than once a day”, “once a day” or
“every two days”. Sporadic WG consumers were those who answered, “at least once a week” or “once
a month”. Non-consumers were those that reported that they “never consume WG foods”.
The consumption of fruits, vegetables and legumes were selected as dietary covariates because
they are also important sources of dietary fiber. Consumption of fruits and vegetables was estimated
through the questions: “Typically, how many days a week do you eat fruits?” and “Typically, how
many days a week do you eat vegetables or vegetable salad? (do not include legumes or potatoes)”,
respectively. The answers in days per week were used as continuous variables. Consumption of
legumes was assessed through the question: “How often do you consume any type of legumes, such as
beans, lentils, green peas or chickpeas?” They were grouped into three categories: (i) “two or more
times per week”, (ii) between “at least once a week” and “between one and three times a month”,
and (iii) “less than once a month or never”.
2.3. Assessment of Risk Factors for Cardiorenal Metabolic Disease
Waist circumference was measured at the midpoint between the costal margin and the iliac
crest. Medication use for diabetes and BP was self-reported. BP was measured three times and
the mean was used in the study. Fasting blood samples (at least 8 h fast) were drawn for the
evaluation of glucose, hemoglobin A1c (HbA1c), creatinine and plasma lipids by standardized
methods in a centralized laboratory as described previously. A morning urine sample was collected
at the moment of the visit (7–10 am) to measure the urinary albumin-creatinine ratio (uACR) [10].
Urinary albumin values below the lowest reportable value (<0.003 g/L) were replaced by 0.003 g/L and
included in the analysis. Very low-density lipoprotein-cholesterol (VLDL-C) and non-high-density
lipoprotein-cholesterol (non-HDL-C) and the triglycerides/HDL-C ratio were calculated. The Chronic
Kidney Disease-Epidemiology Collaboration (CKD-EPI) formula was used to estimate the glomerular
filtration rate (GFR) [11].
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2.4. Outcomes
Metabolic syndrome was defined according to the Chilean National Guidelines as having
at least three of the following five components: high waist circumference (>90 cm for men and
>80 cm for women), low HDL (HDL-C <1.03 mmol/L for men and <1.29 mmol/L for women),
hypertriglyceridemia (triglycerides ≥ 1.7 mmol/L), high BP (systolic/diastolic BP > 130/85 mmHG
or under BP-lowering treatment) and impaired fasting glucose (IFG, glucose > 5.6 mmol/L or under
treatment with antidiabetic drugs) [10]. A GFR < 60 mL/min.1.73 m2 was used to define chronic kidney
disease (CKD) according to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines [12].
uACR was available in 2432 participants. Albuminuria was categorized as microalbuminuria:
uACR between 0.34–3.39 mg/mmol, and macroalbuminuria: uACR > 3.39 mg/mmol according to
guidelines [12].
2.5. Socio-Demographic and Clinical Covariates
Covariates to be included in the study were selected a priori and were based on previous
reports of the 2016–2017 Chilean National Health Survey and in a pathophysiological basis [13,14].
Trained interviewers collected socio-demographic data from all participants including geographical area
(urban vs. rural), age (years), sex, education level (<8, 8–12, >13 years of education), body mass index
(BMI, <25, 25–30, >30 kg/m2), physical activity using the Global Physical Activity Questionnaire (GPAQ,
low, moderate, high), tobacco use (current smokers vs. non-smokers and former smokers), frequency
of alcohol consumption (never, ≤1 time/month, 2–4 times/month, 2–3 times/week, >3 times/week)
and number of glasses of alcohol typically consumed (continuous, 0 for non-drinkers), hypertension
(self-reported, medication use or systolic/diastolic BP > 140/90 mmHg), diabetes (self-reported
or fasting blood glucose > 7 mmol/L) and previous cardiovascular disease (self-reported acute
myocardial infarction, stroke or peripheral artery disease). Less than 1% of the participants showed a
BMI < 18.5 kg/m2 and they were included within the BMI category < 25.0 kg/m2. Alcohol dependence
was 0.3% in the Survey and these participants were not excluded from the study.
2.6. Statistical Analyses
The complex sampling design of the Chilean National Health Survey including strata, cluster and
weights were considered for all statistical analyses. Sampling weights and their instructions for use
were provided in the database. Categorical data are presented as percentage (standard error, SE), unless
otherwise stated. Continuous variables are shown as mean (SE). Generalized linear models adjusted
for age (18–24, 25–44, 45–64, >65 years) and sex were used to compare the general characteristics
of the population and the levels of risk factors for CRMD across categories of WG consumption.
Among these biochemical variables, the skewed-distributed variables were log-transformed before
being entered in the analysis. The association between WG consumption and each metabolic syndrome
component, metabolic syndrome and CKD was tested using a multivariable logistic regression.
The association between WG consumption and albuminuria was tested by multivariable ordinal
regression. Odds Ratios (OR) and 95% CI were calculated using the following modeling strategy.
Model 1 was adjusted by age (18–24, 25–44, 45–64, >65 years), sex and geographical area. Model 2
was additionally adjusted for BMI (<25, 25–30, >30 kg/m2), education level (<8, 8–12, >13 years
of education), tobacco use (current smokers vs. former and non-smokers), frequency of alcohol
consumption (never, ≤1 time/month, 2–4 times/month, 2–3 times/week, >3 times/week) and number
of glasses of alcohol typically consumed (continuous, 0 for non-drinkers), physical activity (GPAQ,
low, moderate, high), diabetes (self-reported or fasting blood glucose >126 mg/dl) and previous
cardiovascular disease (self-reported acute myocardial infarction, stroke or peripheral artery disease).
For renal outcomes (CKD and albuminuria) the model also included hypertension (self-reported,
medication use or systolic/diastolic BP > 140/90 mmHg). Model 3 was further adjusted for consumption
of fruits, vegetables (times per week) and legumes (categorical, three levels). Interactions between
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WG consumption and age (categorical), sex, BMI (categorical), education level (categorical), physical
activity (categorical) and tobacco use in relation to the risk factors for CRMD were tested by using a
likelihood ratio test based on the models with and without an interaction term. If it was significant,
the analyses were divided into subgroups. Sensitivity analysis excluding participants from rural areas,
having a BMI < 18.5 kg/m2, participants with alcohol dependence, patients with diabetes and previous
cardiovascular disease was also conducted. SPSS version 25 (IBM, Armonk, NY, USA) was used for all
statistical analyses.
3. Results
3.1. General Characteristics of the Population According to the Frequency of WG Consumption
The studied population consisted of 3110 participants and after applying sampling weights
this population was representative of a total n (95%CI) of 11,810,647 (10,982,016–12,639,278) subjects.
General characteristics are shown in Table 1. In general, the Chilean population featured an elevated
prevalence of overweight/obesity (77.5%), metabolic syndrome (41.7%), and physical inactivity
(34.7%). The prevalence of hypertension, diabetes and cardiovascular disease was 27.1%, 12.8% and
9.6%, respectively.
Regular WG consumers were younger, more likely to reside in urban areas, to be women,
non-smokers or former smokers and to have a higher education level and physical activity than
sporadic and non-WG consumers (Table 1). The consumption of fruits and vegetables per week was
higher in regular WG consumers and they typically consumed fewer glasses of alcohol (although they
did not consume alcohol more frequently). There were no differences in the prevalence of diabetes or
previous cardiovascular disease across categories of WG consumption (Table 1).
Table 1. General characteristics of the participants according to the frequency of wholegrain
(WG) consumption.





Interviewed participants (n) 3110 1739 613 758
Weighted population (n,%) 11,810,647 (100) 6,369,362 (54) 2,316,451 (20) 3,124,834 (26)
Age (years) 44.2 (0.5) 47.1 (0.8) 42.2 (1.1) 40.0 (0.9) <0.001
Urban residents (%) 88.9 (0.7) 86.0 (1.1) 90.1 (1.5) 94.1 (1.1) <0.001
Female sex (%) 51.5 (1.4) 48.3 (1.8) 54.9 (3.3) 55.5 (3.5) 0.025
Education level (%)
<0.001
<8 years 17.1 (1.1) 22.6 (1.7) 10.3 (1.5) 11.0 (2.0)
8–12 years 54.5 (1.9) 58.9 (2.3) 54.8 (3.3) 45.4 (3.4)
>12 years 28.4 (1.8) 18.5 (1.9) 35.0 (3.4) 43.6 (3.6)
BMI category (%)
0.320<25 kg/m
2 22.5 (1.4) 21.2 (1.7) 19.8 (2.7) 27.0 (3.0)
25–30 kg/m2 42.7 (1.8) 42.5 (2.3) 46.2 (3.5) 40.5 (3.2)
>30 kg/m2 34.8 (1.5) 36.3 (2.0) 33.9 (3.1) 32.5 (3.1)
PA (%)
0.044
Low 34.7 (1.5) 37.3 (2.1) 31.4 (3.2) 32.0 (3.0)
Moderate 23.8 (1.4) 24.5 (1.8) 23.8 (2.8) 22.2 (2.8)
High 41.5 (1.8) 38.2 (2.3) 44.8 (3.5) 45.7 (3.4)




Never 27.1 (1.3) 25.4 (1.5) 25.4 (2.7) 31.6 (3.0)
≤1 time/month 37.6 (1.5) 39.0 (2.0) 34.1 (3.2) 37.1 (3.0)
2–4 times/month 24.8 (1.4) 25.2 (2.0) 29.6 (3.4) 20.4 (2.3)
2–3 times/week 7.9 (1.1) 7.5 (1.4) 9.1 (2.2) 8.0 (2.0)
>3 times/week 2.6 (0.5) 2.9 (0.7) 1.8 (0.8) 2.8 (1.1)
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Table 1. Cont.






(glasses) 2.2 (0.1) 2.4 (0.1) 2.2 (0.1) 1.9 (0.1) <0.001
Fruits (times/week) 4.3 (0.1) 4..0 (0.1) 4.4 (0.1) 5.1 (0.2) <0.001
Vegetables (times/week) 5.5 (0.1) 5.4 (0.1) 5.6 (0.1) 5.8 (0.1) 0.008
Legumes (%)
0.503
≤1 time/month 12.1 (1.1) 11.7 (1.3) 12.4 (2.4) 12.5 (2.4)
>1 time/month 62.8 (1.8) 62.8 (2.3) 65.9 (3.3) 60.7 (3.1)
≥2 times/week 25.1 (1.4) 25.5 (1.8) 21.7 (2.8) 26.8 (2.9)
HT (%) 27.1 (1.3) 31.5 (1.9) 27.9 (3.1) 17.7 (2.1) 0.164
Diabetes (%) 12.8 (1.0) 13.0 (1.4) 12.4 (1.8) 12.6 (2.1) 0.368
CVD (%) 9.6 (0.9) 11.0 (1.3) 9.4 (1.8) 6.8 (1.2) 0.396
MetS (%) 41.7 (1.6) 45.2 (2.1) 42.3 (3.3) 34.1 (3.3) 0.323
CKD (%) 2.9 (0.5) 3.6 (0.7) 3.5 (1.1) 1.1 (0.3) 0.181
uACR (%)
0.9620.34–3.39 mg/mmol 8.3 (0.8) 7.4 (0.9) 10.1 (2.0) 8.7 (2.1)
>3.39 mg/mmol 1.4 (0.3) 1.7 (0.5) 1.5 (0.7) 0.9 (0.4)
BMI, body mass index; PA, physical activity; HT, hypertension; CVD, cardiovascular disease; MetS, metabolic
syndrome; CKD, chronic kidney disease; uACR, urinary albumin-creatinine ratio. * Generalized linear models
adjusted for age and sex. Available data in uACR (2432 interviewed participants representing a population
of 8,385,402).
3.2. Risk Factors for CRMD According to the Frequency of WG Consumption
The prevalence of hypertension, metabolic syndrome and CKD was similar across categories of
WG consumption (Table 1).
However, WG consumers showed lower levels of several risk factors for CRMD than sporadic
WG consumers and non-consumers in age- and sex-adjusted models (Table 2). In particular, regular
WG consumers showed lower systolic/diastolic BP and a less atherogenic lipid profile characterized by
higher HDL-C and lower triglycerides and VLDL-C (Table 2). Markers of renal function (creatinine,
GFR and uACR) were similar across categories of WG consumption.









WC (cm) 94.5 (0.5) 93.6 (0.9) 91.7 (0.8) 0.156
SBP (mmHg) 126.1 (0.8) 124.1 (1.4) 118.7 (0.9) 0.006
DBP (mmHg) 75.6 (0.4) 74.9 (0.7) 72.2 (0.6) 0.007
Glucose (mmol/L) 5.36 (0.04) 5.31 (0.07) 5.11 (0.05) 0.389
HbA1c (mmol/mol) 43.2 (0.8) 45.9 (1.8) 41.6 (1.2) 0.993
TG (mmol/L) 1.72 (0.05) 1.60 (0.09) 1.48 (0.07) 0.007
TC (mmol/L) 4.67 (0.04) 4.66 (0.07) 4.50 (0.06) 0.319
HDL-C (mmol/L) 1.18 (0.01) 1.24 (0.02) 1.25 (0.02) 0.005
LDL-C (mmol/L) 2.70 (0.03) 2.69 (0.06) 2.59 (0.05) 0.459
VLDL-C (mmol/L) 0.78 (0.02) 0.71 (0.04) 0.66 (0.25) 0.008
Non-HDL-C (mmol/L) 3.50 (0.04) 3.42 (0.07) 3.25 (0.06) 0.071
TG/HDL-C 1.7 (0.07) 1.5 (0.1) 1.4 (0.1) 0.003
Creatinine (µmol/L) 70.7 (0.8) 69.5 (1.1) 68.4 (1.1) 0.251
GFR (mL/min.1.73 m2) 101 (1) 104 (1) 106 (1) 0.343
uACR (mg/mmol) 0.28 (0.05) 0.26 (0.04) 0.21 (0.04) 0.990
WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c;
TG, triglycerides; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL,
very low-density lipoprotein; GFR, glomerular filtration rate; uACR, urinary albumin-creatinine ratio. Values are
mean (SE). * Generalized linear models adjusted for age and sex. Available data in HbA1c (1106 interviewed
participants representing a population of 3,335,061) and uACR (2432 interviewed participants representing a
population of 8,385,402). † n after applying sampling weights.
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3.3. Association of WG Consumption with Cardiorenal Metabolic Outcomes
The prevalence of individual metabolic syndrome components in the participants was 76.6% for
high waist circumference, 52.2% for low HDL, 37.6% for high BP, 34.8% for hypertriglyceridemia,
and 24.9% for IFG.
Age-, sex- and geographical area-adjusted models showed an inverse association of WG
consumption with high BP and CKD (Table S1). Results from the fully adjusted model are shown in
Table S1 and Figure 2. Regular WG consumption was significantly associated with a 39% lower risk of
high BP than non-consumers.
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0.43–1.34) and >65 y (ORregularWG vs. non-consumer: 0.71, 95%CI: 0.29–1.72) age groups, but not in the
group of 25–44 y (ORregularWG vs. non-consumer: 1.16, 95%CI: 0.62–2.17). There were no significant
interacti ns betw en WG consumption and the other investigated covari tes (sex, e ucation level,
BMI, physical activity, and tobacco use) of the study for all outcomes.
3.4. Sensitivity Analysis
Excluding participants fro rural areas (n: 1,305,651), with underweight (BMI < 18.5 kg/m2,
n: 107,656), with alcohol dependence (n: 10,770), with diabetes (n: 1,513,041) or previous cardiovascular
disease (n: 1,137,769) sho ed si ilar results for the association bet een G consu ption and high
BP (Table S2). The rest of the results re ained non-significant.
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4. Discussion
This is the first report to show that regular WG consumption is associated with lower levels of
risk factors for CRMD, and especially lower risk of high BP, in a Latin American study. Indeed, regular
WG consumers showed approximately a 39% lower risk of presenting high BP than non-consumers in
this nationwide study representative of almost 12,000,000 Chilean adults.
The inverse association between regular WG consumption and high BP was robust and was
in agreement with other studies [14]. Elevated BP is a known-causal risk factor for cardiovascular
disease. In randomized clinical trials, a 20% reduction in cardiovascular events was observed for each
10 mmHg of lower systolic BP using medical therapy [15]. Indeed, patients with slight elevations of
BP (normal-high BP: 130–139/80–85 mmHg) showed an increased risk of cardiovascular disease [16],
and it was shown that patients with other cardiovascular risk factors may benefit more from lower
BP at any given value [17]. Therefore, the effect of regular WG consumption on BP may contribute
to the prevention of CRMD. It is important to bear in mind that the inverse association between
WG consumption and hypertension was confirmed in prospective studies in the US [18] and Asian
populations [19]. Thus, a great deal of evidence suggests that low WG consumption may be a causal
risk factor for hypertension.
The inverse association between regular WG consumption and high BP may rely, to some extent,
on the anti-inflammatory effects attributed to WG and to one of its major nutrients, dietary fiber [20].
These effects could be mediated by beneficial modification of gut microbiota composition and/or the
enhancement of short-chain fatty acid production [21–23]. Chronic inflammation, typical of obesity
and its metabolic derangements, is a key player in the development and progression of endothelial
dysfunction, and consequently hypertension [24]. Metagenomic and metabolomic studies are needed
to clarify the exact role of gut microbiota composition or its fermentation products in the BP lowering
activities attributed to WG.
In our study, we did not observe a significant association between WG consumption and MetS.
In a study of 827 Tehranian adults [14], participants in the highest quartile of WG intake showed a 32%
lower risk for MetS than those in the lowest quartile. The population characteristics, which included
older participants with a higher prevalence of overweight/obesity, hypertension and diabetes, and the
lack of a quantitative analysis of WG consumption might explain the different results. Moreover, in the
Tehran study, the mean WG consumption was 93 ± 29 g/day, much higher than the estimated mean
consumed in the whole sample of Chilean participants in the ELANS, i.e., ±26 g/day [5]. In fact, in a
US study on dietary fiber and its association with MetS, risk estimates showed an inverse linear trend
across quintiles of intake [25]. Therefore, the low intake level of WG foods in Chile might explain why
we did not observe an association between WG consumption and other CRMD outcomes.
The Nutrition and Chronic Diseases Expert Group (NutriCoDE) [26] showed causal protective
cardiorenal metabolic effects of WG foods and established that an intake of 50 g/day of WG was
associated with a 12% lower risk of coronary heart disease events due to its effects on BP and
LDL-C [26].The optimal WG intake range is still under debate and although a range of 100 to 125 g/day
has been proposed [27], another study suggested that a WG intake of 210–225 g/day was needed to
reduce the risk of chronic diseases and mortality [28]. The HELGA study, which combined samples
from three Scandinavian cohorts with a median WG intake of 121 g/day, showed a 44% and 15%
lower cardiovascular mortality for women and men, respectively, in the highest quartile of WG intake
compared to the lowest one [29]. However, WG foods can provide several health benefits even at low
intake doses. In two large prospective cohort studies from the US with relatively low WG intakes (from
quintile 1 to quintile 5 of 4.3 g/day to 35.6 g/day, and of 5.8 g/day to 52.6 g/day, respectively) the highest
quintiles of WG intake were associated with a 9% lower cardiovascular mortality independent of other
dietary and lifestyle factors [30]. Thus, efforts to promote WG consumption in Chile disregarding
the level of intake are expected to impact the incidence of CRMD. The Food Based Dietary Guideline
for the Chilean population promulgates 11 main statements to define a healthy diet [7]. However,
no message directly alludes to WG. Some probable restraints in the intake of WG foods in the Chilean
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population have already been mentioned such as lower palatability, unawareness of health benefits,
and higher prices compared to refined grain foods [31].
Consumption of WG changes considerably between populations. WG rye products are commonly
consumed in Scandinavian countries, while WG bread and breakfast cereals are common in the US,
and brown rice in Asian countries [28]. Thus, the type of grain may also have some influence when
comparing our results with studies from other geographical regions. In particular, WG oats showed a
potent cholesterol-lowering effect compared to other grains [32]. As shown in the National Survey of
Food Consumption in Chile (ENCA) Survey, the cereals most consumed in Chile were bread and pasta,
while breakfast cereals were seldom consumed. Although, it was not explicitly addressed, WG wheat
was the most likely consumed WG among Chilean participants.
This was a cross-sectional study and causal relationships cannot be ascertained. This study was
based on the frequency of WG consumption and, therefore, future studies quantifying WG intake and its
association with CRMD risk factors in Latin America are warranted. Moreover, energy intake was not
available for adjustment. However, the use of a national representative sample with sampling weights
to adjust for overrepresentation, selection probability, non-response rates, and the poststratification
adjustment, carried out by trained personnel, with centralized laboratory results, are major strengths
of the study. Although the statistical analyses were adjusted by sociodemographic covariates, some
residual confounding cannot be ruled out. In particular, CKD prevalence was somewhat lower than
expected in the sample (2.9%). Indeed, a Chilean study found a prevalence of CKD of 12.1% in primary
care health centers [33]. Finally, the Chilean population has one of the highest prevalence of overweight
and obesity compared to other countries from the region and the results might not be generalized to
the whole region [34]. Nonetheless, this is the first study on the association between WG consumption
and CRMD risk factors carried out in a Latin American country and our results may contribute to
promote research on the cardiorenal metabolic effects of WG foods in the Region.
5. Conclusions
Regular WG consumption was associated with lower levels of risk factors for CRMD and
especially lower risk of high BP. The benefits of regular WG consumption on BP were independent
of socio-demographic characteristics and other dietary sources of fiber. The adjustment for other
dietary fiber sources suggests that additional components within WG may also contribute to its
BP-lowering effects [35]. Considering its health benefits, access to and consumption of WG foods
should be included and promoted by national dietary guidelines and food policies in order to prevent
CRMD in Latin America.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/12/9/2815/s1,
Table S1: Association between WG consumption and cardiorenal metabolic outcomes. Table S2: Sensitivity
analysis of the association between WG consumption and cardiorenal metabolic outcomes.
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